HK1251513A1
|
|
Pipette tip container
|
JP2015033383A
|
|
Hpv detection and quantification by real time multiplex amplification
|
EP2963422A1
|
|
Early prediction markers of diabetic nephropathy
|
FR3019901A1
|
|
CONTROL MARKER FOR THE IMPLEMENTATION OF ANALYSIS METHODS ON SPOTS
|
FR3019654A1
|
|
CONTROLS FOR THE IMPLEMENTATION OF MULTIPLEX ANALYSIS METHODS
|
EP2887068A1
|
|
Method for improving the diagnosis of invasive Candida infections by FBA1 protein detection
|
CA2874688A1
|
|
Method for diagnosing and differentiating hiv-2 infections
|
JP2013055947A
|
|
Use of both rd9 and is6110 as nucleic acid targets for diagnosis of tuberculosis, and provision of multiplex-compliant is6110 and rd9 targets
|
EP2680002A1
|
|
Method for diagnosing invasive Candida infections
|
JP2012161314A
|
|
Hpv detection and quantification by real time multiplex amplification
|
AU2011373900A1
|
|
A2M fragments and applications thereof
|
EP2405271A1
|
|
Markers of vulnerability of the atherosclerosis plaque
|
EP2417028A2
|
|
Device for filling a card typ gel, having means for ionisation
|
EP2294429A2
|
|
Treatment and/or analysis machine with a clamp suitable for gripping a biological sample holder
|
EP2411804A1
|
|
Method for the in vitro diagnosis of stroke
|
EA017206B1
|
|
Multiplex method for detecting an infection
|
AU2006341730A1
|
|
HPV detection and quantification by real-time multiplex amplification
|
EP1872140A2
|
|
Reaction vessel support having pivoting plates, an analyzing device comprising a support of this type, and corresponding analysis method
|
AU2005336287A1
|
|
Use of both RD9 and IS6110 as nucleic acid targets for the diagnosis of tuberculosis, and provision of multiplex-compliant IS6110 and RD9 targets
|